miscellaneous

(P-580) 5-alpha Reductase Inhibitors and the Risk of Anemia Among Men with Benign Prostatic Hyperplasia

(P-585) Association Between Oral Anticoagulants and Risk of Dementia in Patients with Non-valvular Atrial Fibrillation

(P-586) Association Between the Use of Oral Anticoagulant and Risk of Adverse COVID-19 Outcomes: An Opensafely Analysis

(P-596) Insights from a Review of Publicly Available Information on Post Authorisation Safety Studies (PASS)

(P-597) Medical Cannabis Authorization and Drugs and Other Substances Use Disorders: longitudinal Cohort Study

(P-601) Patterns and Predictors of Stimulant Use During Pregnancy

(P-603) Prescription Drug-based Risk Scores: A Systematic Review

(P-604) Risk of Hospitalization and Death Associated with Pimavanserin Use in Older Adults with Parkinson’s Disease

(P-608) Safety of Generic Cyclosporine in Solid Organ Transplant Patients: A Systematic Review and Meta-analysis

(P-610) Short-term Incidence of Thrombotic Events in Patients Who Were Treated with Factor Xa Inhibitors and Hospitalized for Bleeding

(P-613) The Risk of Severe Acute Kidney Injury with Use of Anti-hypertensives in the Elderly: A Self-controlled Case Series Analysis

(P-616) Use of High-dimensional Propensity Scores (hdPS) in a Japanese National Claims Database

(P-617) Use of Natural Language Processed Clinical Notes in an Electronic Health Record (EHR) to Characterize Adverse Events of Mood Disorders

(P-617) Use of Renin-angiotensin-aldosterone System Inhibitors and the Risk of Acute Pancreatitis

(P-618) Use of Potential Nephrotoxic Medications Among Adults with CKD: Parallel Cohort Studies in U.S. and Swedish Routine Care

(P-618) Using Structural Topic Modelling to Reveal Patterns in Reports on Opioid Drugs in a Pharmacovigilance Database

(P-619) Venous Thromboembolism in Patients with Chronic Inflammatory Skin Diseases

(P-620) An Open algorithm to Pre-process Free Text Self-reported Medications Data in UK Biobank

(P-621) Association Between DPP-4 Inhibitors and COVID-19 Related Outcomes Among Patients with Type 2 Diabetes

(P-622) Claims-based Algorithm for Defining Asthma GINA Steps in US Healthcare Database

(P-623) Generating Hypotheses About Never-smoking Lung Cancer Risk Factors Using Large Primary Care Databases

(P-625) Utilization and Long-term Persistence of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Liver Disease

(P-626) What Is Time Zero for Treatment Among Hospitalized Patients with Bacteremia?

(P-627) Evaluation of Machine-learning Algorithms for Predicting Direct-acting Antiviral Treatment Failure in Patients with Chronic Hepatitis C: An HCV-TARGET Analysis

(P-628) Impact of Multimorbidity Subgroups on the Health Care Use, Expenditures, and Clinical Outcomes Among Patients with Tuberculosis: A Population-based Cohort Analysis

(P-629) How Under-coded Is Pediatric Hypertension?: Comparison of Claims and Electronic Health Record (EHR) Data

(P-630) Oral Bisphosphonate Exposure Among Denosumab Users in Ontario, Canada

(P-632) Comparison of the Incidence of Acute Pancreatitis Among New Users of Fluoxetine, Citalopram, and Other Selective Serotonin Reuptake Inhibitors: A Danish Register-based Cohort Study

(P-633) Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Patients with Valvular Atrial Fibrillation: A Population-based Cohort Study

(P-634) Utilization Pattern of Antipsychotics in Patients with Dementia